serum thyroglobulin

Related by string. * Serums . SERUM . serums . Serum : Statens Serum Institut . bovine serum albumin BSA . serum phosphorus levels . serum phosphorus . truth serum . serum markers . serum samples . serum uric acid sUA . qualitative serum . serum albumin . normalize serum uric . eosinophils echocardiogram serum troponin . serum testosterone . serum . serum uric acid / : thyroglobulin * *

Related by context. All words. (Click for frequent words.) 70 thyroglobulin 69 urine cytology 68 alanine aminotransferase ALT 67 PSA nadir 67 serum PSA 66 scintigraphic 65 albumin excretion rate 65 intact parathyroid hormone 65 troponin T 65 F FDG PET 65 spirometric 65 Prostate specific antigen 65 thyroid stimulating hormone 65 Prostate Specific Antigen 65 myeloperoxidase 65 HbA1C 64 aspartate aminotransferase AST 64 lactate dehydrogenase 64 #.#ng/ml 64 CIN3 64 cTnI 64 pelvic lymphadenectomy 64 myocardial necrosis 64 cTnT levels 64 serum ferritin 64 AST ALT 64 urine albumin 64 rheumatoid factor 64 eosinophil count 64 serum TSH 64 ELISPOT 64 specific antigen PSA 64 erythrocyte sedimentation rate 63 D dimer 63 response CCyR 63 PSADT 63 transferrin saturation 63 serum IgE 63 HER2 expression 63 pretest probability 63 CIN2 + 63 glomerular filtration rate 63 pmol L 63 stent stenosis 63 serum homocysteine 63 total thyroidectomy 63 parathyroidectomy 63 HBeAg seroconversion 63 serum HBV DNA 63 thyroid nodules 63 cTnT 63 calculated creatinine clearance 63 SUVmax 63 aminotransferase ALT 63 serum urate 62 advanced adenoma 62 serum bilirubin 62 bronchoalveolar lavage 62 parasitemia 62 HBV DNA levels 62 biochemical recurrence 62 polyp recurrence 62 glycosylated hemoglobin HbA1c 62 HBsAg 62 hemoglobin hematocrit 62 extracapsular extension 62 risk reducing salpingo 62 postoperative morbidity 62 colorectal adenoma 62 PHPT 62 histologic subtype 62 posttransplant 62 #ng/ml 62 antigen PSA levels 62 postoperative mortality 62 alteplase 62 interobserver agreement 62 Lymph node 62 node metastases 62 vasopressor 62 glycated hemoglobin levels 62 Hemoccult II 62 cardiac troponin T 62 thyrotropin 61 baseline LDH 61 p# antigen 61 tracer uptake 61 clinically detectable 61 procalcitonin 61 β blockers 61 NGAL 61 pT3 61 ASCUS 61 μg L 61 glycated hemoglobin 61 pCR 61 Prostate Specific Antigen PSA 61 serum phosphate 61 alanine aminotransferase 61 axillary lymph nodes 61 exhaled nitric oxide 61 Histologic 61 stratifying patients 61 antibody titer 61 intima media thickness 61 intravesical therapy 61 serum cortisol 61 prostate carcinoma 61 haematologic 61 urothelial carcinoma 61 micrometastasis 61 serum testosterone 61 HOMA IR 61 leukocyte count 61 corticosteroid dose 61 NYHA functional class 61 pelvic ultrasound 61 advanced adenomas 61 hematological parameters 61 undetectable HBV DNA 61 carcinoembryonic antigen 61 adenoma recurrence 61 inotropic 61 protein excretion 61 FDG-PET/CT 61 cardiac troponin 61 hemoglobin Hb 61 glomerular filtration 61 N telopeptide 61 MSMB 61 colorectal liver metastases 61 estrogen receptor ER 61 abdominal computed tomography 61 plasma cortisol 61 radiosensitivity 61 locoregional recurrence 61 albumin excretion 61 polyp detection 60 IV bisphosphonates 60 SGPT 60 intraobserver 60 epithelial ovarian cancer 60 bioavailable testosterone 60 plasma creatinine 60 HbA 1c 60 latent tuberculosis TB 60 complete cytogenetic response 60 alkaline phosphatase ALP 60 elevated ALT 60 preoperative PSA 60 antigen PSA 60 natriuretic peptides 60 TMPRSS2 ERG fusion 60 PASI scores 60 obstructive coronary artery 60 oncological outcomes 60 Skin sterol 60 creatine kinase MB 60 VEGF expression 60 aminotransferase 60 urinary N telopeptide 60 pg mL 60 TPMT 60 Tumor shrinkage 60 lymph node metastasis 60 coronary calcification 60 aminotransferases 60 nodal metastases 60 LVNC 60 macroalbuminuria 60 liver histology 60 cytologic 60 urodynamic 60 estimated GFR 60 serum concentrations 60 FDG uptake 60 gastric adenocarcinoma 60 colorectal neoplasms 60 transabdominal 60 biochemical relapse 60 lactate dehydrogenase LDH 60 perioperative morbidity 60 renal cysts 60 primary aldosteronism 60 lowest tertile 60 gadolinium enhanced 60 HER2 overexpression 60 Cystatin C 60 exhaled NO 60 cystoscopic 60 paraprotein 60 CP CPPS 60 obstructive CAD 60 hypericin 60 myocardial perfusion 60 SLNB 60 CK MB 60 metachronous 60 hormone receptor status 60 guaiac 60 AdreView 60 induced sputum 60 perineural invasion 60 serum aminotransferase levels 60 serum ALT 60 serum calcium 60 ERalpha 60 SCr 60 serum lipid levels 60 NMIBC 60 para aortic 60 μg dL 60 serum prostate 60 posttreatment 60 Randomized clinical trials 60 oncologic outcomes 60 diagnosing coronary artery 60 Adenomas 60 operable breast cancer 60 hematopoietic cancers 60 undetectable viral 59 invasive carcinomas 59 Fasting glucose 59 fluorodeoxyglucose positron emission tomography 59 lymphovascular invasion 59 serum folate concentrations 59 serum testosterone levels 59 selenium intake 59 chest radiographs 59 p = #.# [003] 59 R0 resection 59 PCa 59 sensitivity specificity 59 FeNO 59 Immunohistochemical staining 59 methacholine challenge 59 radical prostatectomy RP 59 Ki# 59 ductal cancer 59 thyrotropin levels 59 Proteinuria 59 selenium supplementation 59 serum potassium 59 bone scintigraphy 59 aspartate aminotransferase 59 angiographically 59 cervical carcinoma 59 D Dimer 59 immunochemical fecal occult 59 HNSCC 59 tPSA 59 remnant ablation 59 pulmonary toxicity 59 H. pylori eradication 59 elevated homocysteine 59 #F FDG PET 59 ovarian carcinoma 59 serum IgG 59 elevated serum creatinine 59 ALT normalization 59 seminal vesicle invasion 59 diagnostic modality 59 creatine kinase 59 multivariable analysis 59 anemia hemoglobin 59 serum uric acid 59 immunohistochemical 59 homocysteine concentrations 59 μmol L 59 HER2 positive cancers 59 retransplantation 59 electrical cardioversion 59 adjuvant therapies 59 hydroxyvitamin D levels 59 differentiated thyroid 59 μg ml 59 chest radiography 59 thiazides 59 hemoglobin A1c levels 59 thyroid carcinoma 59 hsCRP levels 59 salmeterol fluticasone propionate 59 intensive statin therapy 59 iPTH 59 overt nephropathy 59 HbA 1c levels 59 μg liter 59 esophagogastroduodenoscopy 59 hepatic arterial 59 chlamydial infection 59 ovarian malignancy 59 #dhTxB# 59 nonalcoholic steatohepatitis NASH 59 Hb A1C 59 tissue oxygenation 59 microsatellite instability 59 spiral computed tomography 59 pT2 59 dehydroepiandrosterone sulfate 59 intestinal mucosal 59 SpO 2 59 bladder tumors 59 underwent coronary angiography 59 Postoperative complications 59 glycated hemoglobin HbA1c 59 fibrin deposition 59 aromatase inhibitor therapy 59 Radical prostatectomy 59 mucinous 59 plasma leptin 59 Papillary 59 bFGF 59 sleeve lobectomy 59 distant metastases 59 C Reactive Protein 59 DAS# [002] 59 transgene expression 59 transcranial Doppler ultrasound 59 nephrotoxicity 59 histopathological 59 serum urate levels 59 beta blocker therapy 59 serum parathyroid hormone 59 scintigraphy 59 gastric cardia 59 arteriography 59 cardiac perfusion 59 SpCO 59 bilateral oophorectomy 59 radiographic progression 59 neutrophil count 59 tHcy 59 prostate cancer CaP 59 OGTT 59 Crohn Disease Activity 59 elevated LDH 59 Helicobacter pylori infection 59 8 OHdG 59 PaO 2 59 chemosensitivity 59 transient elastography 59 histopathologic examination 59 postop 59 thrombocytopenic 59 urinary albumin 59 HGPIN 59 aneuploidy screening 59 histological subtype 59 epithelial tumors 59 SGRQ 59 viral titers 59 isoprostane 59 carotid IMT 59 tumor histology 59 EUS FNA 59 BRCA2 mutation carriers 59 mCi 59 androgen ablation 58 serum HCV RNA 58 echocardiographic parameters 58 STRIDE PD 58 mutated K ras 58 adenoma detection 58 cystatin C 58 hepatorenal syndrome 58 nodal metastasis 58 distant metastasis 58 lymphadenectomy 58 gastric carcinoma 58 Serum creatinine 58 inducible nitric oxide synthase 58 interleukin IL -6 58 virologic response 58 serum biomarker 58 microvessel density 58 chlamydial 58 apolipoprotein B 58 triiodothyronine 58 carotid stenosis 58 NAbs 58 adrenalectomy 58 QuantiFERON TB Gold 58 endometrial biopsy 58 urodynamic parameters 58 Hemoglobin A1c 58 postoperative complication 58 #OHD 58 preoperatively 58 H pylori 58 B7 H3 58 NNRTI resistance 58 lymphocyte count 58 FDG PET imaging 58 Circulating tumor cells 58 skin sterol 58 transrectal ultrasound guided 58 axillary dissection 58 axillary lymph node 58 urine NGAL 58 Alanine 58 mm ³ 58 pulmonary arterial 58 virological response 58 serum PTH 58 detecting colorectal cancer 58 paricalcitol 58 HBeAg 58 creatinine ratio 58 pleural fluid 58 neutrophil gelatinase associated lipocalin 58 postoperative pulmonary 58 rs# [002] 58 PCWP 58 mediastinal 58 oral anticoagulation 58 hemoglobin A1C 58 Cytogenetic 58 apolipoproteins 58 #/#mmHg 58 serum glucose 58 HSCT 58 prostate specific 58 immunostaining 58 clinically insignificant 58 electron beam computed tomography 58 inhibin 58 thromboembolic disease 58 histopathologic 58 IgG4 58 fasting triglycerides 58 HIV RNA 58 semiquantitative 58 QTc prolongation 58 left ventricular diastolic 58 EGFR TKI 58 distal colon 58 RECIST Response Evaluation Criteria 58 myocardial viability 58 sarcosine 58 serum lactate 58 #F FDG 58 Y BOCS 58 surrogate markers 58 lobular carcinoma 58 helical CT 58 interobserver 58 ejection fractions 58 mycophenolate mofetil 58 leiomyomas 58 elevated transaminases 58 grade cervical intraepithelial 58 ultrasonographic 58 TURBT 58 precursor lesions 58 pentoxifylline 58 oral antidiabetic medication 58 Hcy 58 Homocysteine levels 58 FOLFOX6 58 neurocognitive function 58 conventional coronary angiography 58 TOP2A gene 58 catheter angiography 58 ventilation perfusion 58 #OHD levels 58 urothelial bladder cancer 58 serous ovarian cancer 58 cytoreductive nephrectomy 58 PSA kinetics 58 hs CRP 58 colonoscopic 58 nodal dissection 58 thiopurine 58 5alpha reductase 58 plasma lipoprotein 58 variant allele 58 pneumonectomy 58 % CI #.#-#.# [003] 58 albuminuria 58 HIV tropism 58 CCyR 58 HER2 gene 58 intraocular pressure IOP 58 NMP# 58 parasitaemia 58 TRUS biopsy 58 Microalbuminuria 58 anti JCV antibodies 58 LV ejection fraction 58 platelet reactivity 58 lymph node biopsies 58 FISH fluorescence 58 endocrine therapies 58 isoenzyme 58 Liver biopsy 58 troponins 58 tumor perfusion 58 hepatic enzymes 58 plasma renin 58 carotid plaque 58 carotid bruit 58 microalbumin 58 sputum eosinophils 58 cytological 58 metabolite concentrations 58 intraoperative complications 58 serum vitamin D 58 ductal breast cancer 58 lipoprotein Lp 58 mL/min/#.# m2 58 primary hyperparathyroidism 58 CCP antibodies 58 transdermal estradiol 58 microalbuminuria 58 dysuria 58 localized renal 58 KRAS status 58 fulvestrant 58 Akt activation 58 CD# upregulation 58 radioiodine therapy 58 fFN 58 liver metastasis 58 serum estradiol 58 complete cytogenetic 58 International Normalized Ratio 58 morphometric vertebral fractures 58 myocardial reperfusion 58 bladder carcinoma 58 HRCT 58 thyroid stimulating hormone TSH 57 Oral corticosteroids 57 nephrogenic 57 cervical intraepithelial neoplasia 57 artery stenosis 57 tumor necrosis 57 cytokeratin 57 enhanced sonography 57 Viral load 57 plasma selenium 57 Bone density 57 arthrography 57 pulmonary infiltrates 57 cirrhotic patients 57 colorectal cancer CRC 57 locoregional 57 PCA3 scores 57 mmHg diastolic 57 DAS# CRP 57 elevated creatinine 57 leukocyte counts 57 Surgical excision 57 cobalamin 57 univariate analysis 57 sentinel nodes 57 serum triglycerides 57 colorectal adenocarcinoma 57 transesophageal echocardiography 57 nitrotyrosine 57 endometrial thickness 57 symptomatic intracranial hemorrhage 57 RQ PCR 57 coronary arteriography 57 Chlamydia trachomatis infection 57 salivary flow 57 postprocedure 57 hydroxy vitamin D 57 diabetes mellitus DM 57 CI -#.# 57 squamous cell lung cancer 57 microdose 57 pathologic examination 57 latent tuberculosis infection 57 axillary node 57 KRAS mutation 57 EpCAM expression 57 HbF 57 renal cell carcinomas 57 hormone receptor negative 57 #mg dose [002] 57 Inhibin B 57 glycosylated hemoglobin levels 57 precancerous cervical lesions 57 chemoradiation therapy 57 transaminase levels 57 kidney allograft 57 Her2/neu 57 platelet inhibition 57 colorectal carcinoma 57 tumoral 57 estimated glomerular filtration 57 serum creatinine 57 ibandronate 57 sinonasal 57 subclinical hyperthyroidism 57 inflammatory biomarkers 57 clinicopathological 57 radiographic findings 57 transvaginal sonography 57 Creatinine 57 C telopeptide 57 elevated CRP 57 metastatic lymph nodes 57 deCODE BreastCancer TM 57 varus deformity 57 FDG PET scans 57 airway hyper responsiveness 57 sonographically guided 57 sFlt 1 57 IU ml 57 rhTSH 57 sentinel lymph node biopsy 57 ApoB 57 mIU ml 57 follicle stimulating hormone FSH 57 serum creatinine levels 57 BRAF V#E mutation 57 postoperative hemorrhage 57 breast carcinoma 57 androgen deprivation 57 Ishak fibrosis score 57 intrahepatic 57 immunochemical 57 pathologic diagnosis 57 Hurthle cell 57 detectable HCV RNA 57 Preoperative 57 chemoradiotherapy 57 liver resection 57 Cardiorespiratory fitness 57 adrenocortical 57 GnRH agonist 57 T1a 57 paroxysmal AF 57 LV dysfunction 57 serum lipid 57 systemic toxicity 57 Kinoid 57 crossclamp 57 Prothrombin 57 airway responsiveness 57 transaminase elevations 57 acetylcysteine 57 systolic dysfunction 57 advanced neoplasia 57 Coronary artery calcium 57 graft dysfunction 57 Leydig cell 57 TIMP 57 abnormal cytology 57 TP# mutations 57 amyloid deposition 57 atherogenic dyslipidemia 57 extracolonic findings 57 bezafibrate 57 MetS 57 autoantibody levels 57 endometrial carcinoma 57 intravascular ultrasonography 57 androgen suppression therapy 57 transaminases 57 mucosal healing 57 #.#/#.# mmHg [001] 57 abdominal adiposity 57 endoscopic ultrasonography 57 radical cystectomy 57 androgen suppression 57 epididymal 57 SGOT 57 TNFalpha 57 GSTT1 57 c reactive protein 57 Clusterin 57 postintervention 57 #Gy 57 enteroviral 57 pulmonary metastases 57 urate levels 57 lymphocytosis 57 busulfan 57 recurrent venous thromboembolism 57 urinary calcium 57 endocrine therapy 57 multivariate analyzes 57 nmol liter 57 nonproliferative 57 sUA 57 serum sodium 57 gene amplification 57 MTT assay 57 left ventricular systolic 57 femoral neck fracture 57 adnexal mass 57 arterial elasticity 57 univariate analyzes 57 thymosin 57 vascular reactivity 57 somatostatin receptor 57 skeletal metastases 57 RT qPCR 57 DEXA scans 57 nicardipine 57 adjuvant radiotherapy 57 antitumor effect 57 malignant nodules 57 adenomatous polyps 57 ELISpot 57 carcinoids 57 pg ml 57 overt hypothyroidism 57 metastatic malignant 57 atorvastatin #mg 57 dyssynchrony 57 conventional angiography 57 logistic regression analyzes 57 K#N 57 recombinant FSH 57 colorectal polyp 57 pulsatility index 57 orchiectomy 57 alanine transaminase 57 serum phosphorous 57 oophorectomy 57 PlGF 57 TMPRSS2 ERG 57 sympathectomy 57 hematologic parameters 57 methemoglobin 57 fasting plasma glucose FPG 57 aortic regurgitation 57 hemoglobin A1c HbA1c 57 pretreatment serum 57 atheroma volume 57 preoperative chemotherapy 57 thyroxine T4 57 NPM1 mutation 57 neoplasias 57 Ejection Fraction 57 peptide BNP 57 systemic corticosteroid 57 BMD measurements 57 TMP SMX 57 B type natriuretic 57 needle aspiration 57 dual endothelin receptor antagonist 56 ischemic lesions 56 endometrial hyperplasia 56 myocardial function 56 International Prostate Symptom 56 B Cell Lymphoma 56 Fasting blood glucose 56 myeloperoxidase MPO 56 Gram stain 56 neurodevelopmental outcome 56 postoperative delirium 56 pretransplant 56 serum CRP 56 fructosamine 56 abacavir lamivudine 56 triglyceride concentration 56 Immunohistochemical 56 mammographic density 56 GI motility 56 fasting insulin 56 thyroid peroxidase 56 metastatic lesions 56 seropositivity 56 chi squared 56 T SPOT.TB 56 nuchal translucency 56 hepatocellular carcinomas 56 chronic prostatitis 56 lung resection 56 CYP#D# genotype 56 heparanase 56 WOMAC pain 56 relapsed MM 56 perioperatively 56 F FLT 56 p tau 56 coronary angiography 56 specific IgE 56 NSTE ACS 56 pulmonary exacerbation 56 postoperative radiotherapy 56 arterial oxygen saturation 56 cinacalcet 56 folate concentrations 56 d dimer 56 colorectal adenomas 56 eplerenone 56 intravascular hemolysis 56 BYSTOLIC 56 plasma adiponectin 56 Tasigna prolongs 56 malondialdehyde MDA 56 LHRH agonists 56 mammographically 56 subclinical hypothyroidism 56 HCV antibody 56 prolonged QT interval 56 BEXXAR Therapeutic Regimen 56 STN stimulation 56 histologic 56 mcg ml 56 atrioventricular block 56 concomitant medications 56 perioperative mortality 56 K ras mutations 56 mRNA expression 56 hemodynamic parameters 56 activated partial thromboplastin 56 invasive carcinoma 56 endothelial activation 56 histological examination 56 epoetin alpha 56 adenoma 56 Troponin T 56 benign nodules 56 immunohistochemical analysis 56 cytoreduction 56 methylmalonic acid 56 neutrophil counts 56 hepatic enzyme 56 CC genotype 56 poor metabolizers 56 Lp PLA 2 56 HER2 amplification 56 transthoracic 56 precancerous cervical 56 glycosylated hemoglobin 56 carotid artery thickness 56 â ‰ ¥ 56 LDL Cholesterol 56 coronary stenosis 56 incidentalomas 56 CK # plasma concentrations 56 TT genotype 56 TIMP 1 56 phototoxicity 56 CTAP# Capsules 56 Index CDAI 56 anagrelide 56 confidence intervals CIs 56 Quantitation 56 nonmelanoma skin cancers 56 binary restenosis 56 ALT elevation 56 hematologic abnormalities 56 hyperplastic polyps 56 plasma renin activity 56 immunosuppressant therapy 56 PBDE chemicals 56 lung nodule 56 Alkaline Phosphatase 56 lymph node metastases 56 plasma pharmacokinetics 56 urine dipstick 56 T2 lesions 56 Insulin sensitivity 56 hemoglobin concentration 56 Secondary endpoints included 56 mesangial 56 cerebral oxygen saturation 56 Score IPSS 56 QRS duration 56 vaginal pH 56 plasma homocysteine 56 pharmacologic stress 56 Endocrine Therapy 56 serum folate 56 ACTH 56 postoperative atrial fibrillation 56 cervical secretions 56 echocardiographic 56 chromosomal aberrations 56 MMSE scores 56 ABCB1 56 sputum cultures 56 Helicobacter pylori eradication 56 Hypotension 56 luminal diameter 56 cytogenic 56 ADAS Cog 56 mmol l 56 graft occlusion 56 cardiac repolarization 56 periprosthetic infection 56 % Confidence Interval 56 P = .# 56 pulmonary resection 56 pancreatic lung 56 clinically localized prostate 56 zoledronate 56 hip BMD 56 testosterone supplementation 56 serum BDNF 56 PTEN protein 56 mg/m2 dose 56 mIU L 56 Intraocular pressure 56 posaconazole 56 -#.# log# 56 circulating endothelial cells 56 abnormal glucose metabolism 56 cystectomy 56 imatinib therapy 56 vitamin K1 56 systolic hypertension 56 progesterone receptor PR 56 FENO 56 permanently discontinue Vectibix 56 FXIII 56 DAS# remission 56 eNO 56 glycoprotein IIb IIIa inhibitors 56 Stent thrombosis 56 prospectively defined 56 postoperative AF 56 HIV HCV coinfected 56 electrophysiologic 56 sitosterol 56 EBUS FNA 56 interferon beta therapy 56 cytologic examination 56 PKC inhibitors 56 LDL HDL 56 asymptomatic carotid stenosis 56 chloride secretion 56 degranulation 56 EDARBI 56 microbiologically evaluable 56 graft patency 56 ductal lobular 56 serum phosphate levels 56 prostate abnormalities 56 lupus anticoagulant 56 hamartomas 56 maternal serum 56 adjuvant cisplatin 56 gadobutrol 56 mesilate 56 Immunohistochemistry 56 computed tomography scans 56 rechallenge 56 methotrexate therapy 56 opacification 56 Subgroup analysis 56 EBRT 56 NIH CPSI 56 prognostic indicator 56 Troponin 56 idraparinux 56 radiotherapy RT 56 ADPKD 56 arterial calcification 56 Immune responses 56 IFN beta 56 hypoperfusion 56 natriuretic peptide 56 colorectal tumor 56 antioxidant supplementation 56 diabetic kidney 56 Homocysteine 56 DEXA scan 56 prognostic indicators 56 achieved ACR# 56 antiangiogenic therapy 56 CR nPR 56 coronary artery calcium 56 -#.# ± [002] 56 obstructive coronary 56 diagnose Alzheimer disease 56 MR spectroscopy 56 urothelial cancer 56 brain natriuretic peptide 56 colonic polyps 56 leukocytosis 56 Postoperative 56 serum albumin 56 IGFBP 56 Visual Analogue Scale VAS 56 #.#mmol L [002] 56 COHb 56 HRQOL 56 sub maximal 56 Dasatinib 56 SERCA2a 56 lesional 56 manometry 56 tumor resection 56 S#A# [002] 56 #F fluorodeoxyglucose 56 hepatic fat 56 ACR# responses 56 F FDG uptake 56 Natalizumab 56 ERBB2 56 CTEPH

Back to home page